Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Aditxt Inc
ADTX
Healthcare
Biotechnology
Aditxt, Inc. is a biotech company focused on discovering, developing, and deploying health innovations. It develops and commercializes technologies with a focus on monitoring and modulating the immune system. Its portfolio includes Adimune, Inc., developing a new class of therapeutics designed to retrain the immune system to address organ rejection, autoimmunity, and allergies; Adivir, Inc...
., focused on identifying, developing, and commercializing new ways to treat infectious diseases, and Pearsanta, Inc., offering personalized lab testing, backed by CLIA-certified and CAP-accredited monitoring center. Adimune, Inc's immune modulation product candidate, ADI-100, is based on the Apoptotic DNA Immunotherapy platform technology, utilizes a novel approach that mimics the way bodies naturally induce tolerance to own tissues. It also offers electroencephalography (EEG) brain monitoring technologies and devices, including NeuroCap and NeuroEEG for telehealth and tele-neurology applications.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ADTX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
Next
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 03, 2024 11:33am
ADTX....2nd add ...
Cheaper than the 1st I'm Henry the VIII I am
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 03, 2024 11:31am
ADTX.....N.L.O.D $1.80
Now $2 Make it go lower Mr. M
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 03, 2024 10:08am
ADTX....double tap on L.O.D $1.98
bouncing up and above VWAP
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Oct 03, 2024 10:07am
RE:ADTX....now dow 50 % from RS price ; )
Down *
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 03, 2024 9:45am
ADTX....now dow 50 % from RS price ; )
What a "train Wreck" !!!!!!!!!!!!!!!!!!!! Sub $2 anyone
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 03, 2024 8:44am
ADTX.....Why do I smell a rat ?????
How often do you hear a Co publically announce in a News Release that they have an "effective" Shelf P.O ....let me tell you...... Not very often and almost NEVER!! I have to dig and
...more
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Oct 03, 2024 8:20am
RE:ADTX.....There is a filing that one should be cognizant of..
Right from "the horses mouth"......as I mentioned ; ) Aditxt Delivers Shareholder Update and 2024 Year-End Plan 2024-10-03 05:15 ET - News Release
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 03, 2024 8:15am
New Press Release - Aditxt Delivers Shareholder Update and 2024 Year-End Plan
Acquisition target Evofem reported revenue of $7.8 million for the six months ended June 30, 2024 Acquisition target Appili has received approximately $6.0 million of the total $14.0 million to date in a non-dilutive funding commitment from DoD Shelf registration statement and resale...
read article.
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 02, 2024 3:58pm
ADTX.... 1st add
sub $2.70.... Cheers !
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Oct 02, 2024 3:57pm
RE:ADTX.....LoL...2x's tap on L.O.D
4 minutes til close.....N.L.O.D $2.70 Whack the bid
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 02, 2024 3:39pm
ADTX.....LoL...2x's tap on L.O.D
$2.75
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 02, 2024 2:49pm
ADTX.....start the drumroll...here comes N.L.O.D ; )
Whack away Mr. M ..... here is the Exercise on how to fluff up 244K shs o/s ; ) the Company will have approximately 244,667 shares of common stock issued and outstanding.
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 02, 2024 2:11pm
ADTX.....Sage advice ; )
Rapidly rising or falling markets usually go further than you think, but they do not correct by going sideways. Markets correct by going in the opposite direction, falling sharply after sustained
...more
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Oct 02, 2024 2:00pm
RE:ADTX....here comes the "rug pull"
Already double tapped the L.O.D of $2.85.....so that is support until it's breached Stay tuned for more fireworks......whack the bid Mr. M
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 02, 2024 11:46am
ADTX....here comes the "rug pull"
Maybe....$2.99
Prev
1
2
3
4
5
6
7
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
Learn How this Company is Disrupting Point-of-Care Testing
Why Dozens of Pro Athletes are Paying Attention to this Product
Do you want to stay ahead of the markets? See how DealRoom can help.
Debt-Free Cannabis Company Set for Next Stage of Growth